These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 34292451)

  • 21. How I treat bleeding in hereditary hemorrhagic telangiectasia.
    Al-Samkari H
    Blood; 2024 Aug; 144(9):940-954. PubMed ID: 38864625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral itraconazole for epistaxis in hereditary hemorrhagic telangiectasia: a proof of concept study.
    Kroon S; Snijder RJ; Hosman AE; Vorselaars VMM; Disch FJM; Post MC; Mager JJ
    Angiogenesis; 2021 May; 24(2):379-386. PubMed ID: 33211216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TIMolol nasal spray as a treatment for epistaxis in hereditary hemorrhagic telangiectasia (HHT) - Study protocol of the prospective, randomized, double-blind, controlled cross-over TIM-HHT trial.
    Andorfer KEC; Seebauer CT; Koller M; Zeman F; Berneburg M; Fischer R; Vielsmeier V; Bohr C; Kühnel TS
    Clin Hemorheol Microcirc; 2022; 80(3):307-315. PubMed ID: 34864649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High Rates of Bleeding Complications among Hospitalized Patients with Hereditary Hemorrhagic Telangiectasia in the United States.
    Brinjikji W; Wood CP; Lanzino G; Cloft HJ; Misra S; Kallmes DF; Kamath P; Pruthi RK; Krowka MJ; Swanson KL; Iyer VN
    Ann Am Thorac Soc; 2016 Sep; 13(9):1505-11. PubMed ID: 27387823
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blessing for the bleeder: bevacizumab in hereditary hemorrhagic telangiectasia.
    Epperla N; Hocking W
    Clin Med Res; 2015 Mar; 13(1):32-5. PubMed ID: 24667223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Septectomy and septal dermoplasty for the treatment of severe transfusion-dependent epistaxis in patients with hereditary hemorrhagic telangiectasia and septal perforation.
    Lesnik GT; Ross DA; Henderson KJ; Joe JK; Leder SB; White RI
    Am J Rhinol; 2007; 21(3):312-5. PubMed ID: 17621815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Topical propranolol improves epistaxis in patients with hereditary hemorrhagic telangiectasia - a preliminary report.
    Mei-Zahav M; Blau H; Bruckheimer E; Zur E; Goldschmidt N
    J Otolaryngol Head Neck Surg; 2017 Oct; 46(1):58. PubMed ID: 28978360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intermittent low-dose bevacizumab in hereditary hemorrhagic telangiectasia : A case report.
    Huemer F; Dejaco M; Grabmer C; Melchardt T; Neureiter D; Mayer G; Egle A; Greil R; Weiss L
    Wien Klin Wochenschr; 2017 Feb; 129(3-4):141-144. PubMed ID: 27878613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Young's procedure for severe epistaxis from hereditary hemorrhagic telangiectasia.
    Richer SL; Geisthoff UW; Livada N; Ward PD; Johnson L; Mainka A; Henderson KJ; Maune S; White RI; Ross DA
    Am J Rhinol Allergy; 2012; 26(5):401-4. PubMed ID: 23168156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thalidomide for the Management of Bleeding Episodes in Patients with Hereditary Hemorrhagic Telangiectasia: Effects on Epistaxis Severity Score and Quality of Life.
    Baysal M; Ümit EG; Kırkızlar HO; Özdöver AC; Demir AM
    Turk J Haematol; 2019 Feb; 36(1):43-47. PubMed ID: 29880465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gastrointestinal bleeding in patients with hereditary hemorrhagic telangiectasia.
    Kjeldsen AD; Kjeldsen J
    Am J Gastroenterol; 2000 Feb; 95(2):415-8. PubMed ID: 10685743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Laser-Assisted Control of Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Systematic Review.
    Abiri A; Goshtasbi K; Maducdoc M; Sahyouni R; Wang MB; Kuan EC
    Lasers Surg Med; 2020 Apr; 52(4):293-300. PubMed ID: 31441079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of thalidomide therapy for refractory epistaxis in hereditary haemorrhagic telangiectasia: systematic review.
    Harrison L; Kundra A; Jervis P
    J Laryngol Otol; 2018 Oct; 132(10):866-871. PubMed ID: 30191780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intranasal submucosal bevacizumab for epistaxis in hereditary hemorrhagic telangiectasia: a double-blind, randomized, placebo-controlled trial.
    Riss D; Burian M; Wolf A; Kranebitter V; Kaider A; Arnoldner C
    Head Neck; 2015 Jun; 37(6):783-7. PubMed ID: 24595923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful therapy with bevacizumab in a case of hereditary hemorrhagic telangiectasia.
    Kochanowski J; Sobieszczańska M; Tubek S; Żurek M; Pawełczak J
    Hum Vaccin Immunother; 2015; 11(3):680-1. PubMed ID: 25839219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A review on clinical management and pharmacological therapy on hereditary haemorrhagic telangiectasia (HHT).
    Zarrabeitia R; Albiñana V; Salcedo M; Señaris-Gonzalez B; Fernandez-Forcelledo JL; Botella LM
    Curr Vasc Pharmacol; 2010 Jul; 8(4):473-81. PubMed ID: 19485912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-estrogen therapy for hereditary hemorrhagic telangiectasia - a long-term clinical trial.
    Yaniv E; Preis M; Shevro J; Nageris B; Hadar T
    Rhinology; 2011 Jun; 49(2):214-6. PubMed ID: 21743879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complications from office sclerotherapy for epistaxis due to hereditary hemorrhagic telangiectasia (HHT or Osler-Weber-Rendu).
    Hanks JE; Hunter D; Goding GS; Boyer HC
    Int Forum Allergy Rhinol; 2014 May; 4(5):422-7. PubMed ID: 24431220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective pilot study of Floseal® for the treatment of anterior epistaxis in patients with hereditary hemorrhagic telangiectasia (HHT).
    Lee JM; Wu V; Faughnan ME; Lasso A; Figol A; Kilty SJ
    J Otolaryngol Head Neck Surg; 2019 Oct; 48(1):48. PubMed ID: 31615556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hereditary hemorrhagic telangiectasia showing severe anemia which was successfully treated with estrogen.
    Hisada T; Kuwabara H; Tsunoda T; Kaneko K; Kubota S; Miwa Y; Mori M
    Intern Med; 1995 Jun; 34(6):589-92. PubMed ID: 7549150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.